'Examining impact': India's first response to 100% pharma tariffs by US

NEW DELHI: India connected Friday issued its archetypal authoritative effect to reports that US President Donald Trump announcing imposition of tariffs of up to 100 per cent connected imports of branded and patented pharmaceutical drugs from October 1.During the play briefing, MEA's authoritative spokesperson Randhir Jaiswal said, “We saw a announcement yesterday connected societal media that talked astir caller tariffs. We've seen the study connected pharma and different products, and the applicable ministry and section are intimately monitoring the substance and examining its impact.”

While Jaiswal did not supply details connected immoderate contiguous diplomatic oregon commercialized responses, helium clarified that applicable ministry officials person taken cognizance and talks volition beryllium held with them for circumstantial details.The improvement comes amid increasing concerns implicit commercialized negotiations betwixt the US and India, enhanced by these caller tariffs, wherever India is simply a starring planetary supplier of some generic and patented medicines.tariffs connected branded and patented pharmaceutical exports has rattled Indian pharma stocks, adjacent though astir Indian companies chiefly gain from generic cause income successful the US. The US is India’s largest pharmaceutical export market, accounting for astir 35 per cent of full exports, valued astatine astir $10 cardinal successful FY25. Experts are assessing the imaginable interaction connected companies that make 30–47 per cent of their gross from US operations, peculiarly if the tariff measures are extended to see analyzable generics and specialty medicines.